| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.615 | 31.857 | 28.760 | 25.120 | 29.097 | 34.454 |
| Total Income - EUR | - | - | - | - | 3.033 | 36.779 | 33.573 | 29.948 | 33.910 | 39.240 |
| Total Expenses - EUR | - | - | - | - | 2.451 | 25.231 | 22.483 | 20.808 | 18.000 | 14.204 |
| Gross Profit/Loss - EUR | - | - | - | - | 582 | 11.548 | 11.090 | 9.140 | 15.910 | 25.036 |
| Net Profit/Loss - EUR | - | - | - | - | 556 | 11.229 | 10.802 | 8.386 | 13.416 | 21.111 |
| Employees | - | - | - | - | 2 | 3 | 3 | 1 | 1 | 1 |
Check the financial reports for the company - Clin Endomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 39.830 | 35.420 | 29.339 | 24.118 | 19.555 | 14.332 |
| Current Assets | - | - | - | - | 11.324 | 8.475 | 7.475 | 5.711 | 10.901 | 19.312 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 9.378 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 1.946 | 8.475 | 7.475 | 5.711 | 10.901 | 19.312 |
| Shareholders Funds | - | - | - | - | 598 | 11.270 | 10.843 | 8.427 | 13.456 | 21.159 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 13.464 | 1.158 | 15 | 193 | 669 | 1.031 |
| Income in Advance | - | - | - | - | 37.092 | 31.467 | 25.956 | 21.209 | 16.332 | 11.454 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Clin Endomed S.r.l.